TABLE 3

Mycobacterium avium complex patients and hospital encounters prescribed regimens active against nontuberculous mycobacteria

Encounters where treatment was receivedPeople who received treatment
Subjects28621326
Macrolide, ethambutol, rifamycin (optional aminoglycoside)#152 (5)129 (10)
Macrolide monotherapy146 (5)143 (11)
Macrolide, quinolone87 (3)84 (6)
Macrolide, rifamycin13 (0)12 (1)
Macrolide, amikacin+1 (0)1 (0)
Macrolide, linezolid+8 (0)8 (1)
Macrolide, other+84 (3)72 (5)
Ethambutol, rifamycin§21 (1)21 (2)
Quinolone-based§306 (11)265 (20)
Aminoglycoside-based§5 (0)4 (0)
Linezolid-based§15 (1)13 (1)
No treatment received2024 (71)681 (51)

Data are presented as n or n (%). #: treatment regimens meeting American Thoracic Society/Infectious Disease Society of America guidelines; : treatment regimens that potentially promote macrolide resistance; +: treatment regiments that are of unknown clinical significance; §: treatment regimens that do not include macrolides.